MEDNAX Inc to Post Q2 2019 Earnings of $0.79 Per Share, Jefferies Financial Group Forecasts (NYSE:MD)

MEDNAX Inc (NYSE:MD) – Jefferies Financial Group reduced their Q2 2019 earnings per share estimates for shares of MEDNAX in a report released on Thursday, July 11th. Jefferies Financial Group analyst J. Plagman now anticipates that the company will earn $0.79 per share for the quarter, down from their previous estimate of $0.80. Jefferies Financial Group currently has a “Hold” rating and a $31.00 target price on the stock.

MEDNAX (NYSE:MD) last issued its earnings results on Thursday, May 2nd. The company reported $0.58 EPS for the quarter, missing the Zacks’ consensus estimate of $0.63 by ($0.05). MEDNAX had a negative net margin of 1.05% and a positive return on equity of 9.82%. The business had revenue of $851.20 million during the quarter, compared to analyst estimates of $906.35 million. During the same quarter last year, the company earned $0.89 earnings per share. MEDNAX’s quarterly revenue was down .2% on a year-over-year basis.

Other equities research analysts have also recently issued reports about the stock. Zacks Investment Research upgraded shares of HB Fuller from a “sell” rating to a “hold” rating in a research report on Wednesday, July 3rd. Citigroup set a $47.00 price objective on shares of Quanta Services and gave the stock a “buy” rating in a research report on Friday, May 3rd. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating and three have issued a buy rating to the stock. MEDNAX presently has a consensus rating of “Hold” and an average target price of $38.36.

MEDNAX stock opened at $24.58 on Friday. MEDNAX has a 12-month low of $23.05 and a 12-month high of $48.77. The firm has a market capitalization of $2.11 billion, a PE ratio of 7.00, a P/E/G ratio of 0.94 and a beta of 0.65. The stock’s 50-day moving average price is $25.39. The company has a current ratio of 2.55, a quick ratio of 2.55 and a debt-to-equity ratio of 0.79.

Several institutional investors and hedge funds have recently made changes to their positions in MD. Quadrant Capital Group LLC increased its position in shares of MEDNAX by 538.6% during the first quarter. Quadrant Capital Group LLC now owns 1,009 shares of the company’s stock valued at $26,000 after acquiring an additional 851 shares during the last quarter. Bremer Bank National Association acquired a new stake in shares of MEDNAX during the first quarter valued at about $30,000. Tompkins Financial Corp increased its position in shares of MEDNAX by 352.8% during the first quarter. Tompkins Financial Corp now owns 806 shares of the company’s stock valued at $38,000 after acquiring an additional 628 shares during the last quarter. Investors Research Corp acquired a new stake in shares of MEDNAX during the first quarter valued at about $41,000. Finally, First Bank & Trust increased its position in shares of MEDNAX by 18.7% during the first quarter. First Bank & Trust now owns 3,334 shares of the company’s stock valued at $90,000 after acquiring an additional 526 shares during the last quarter. Institutional investors and hedge funds own 91.14% of the company’s stock.

MEDNAX Company Profile

MEDNAX, Inc, together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, radiology and teleradiology, pediatric cardiology, and other pediatric subspecialty physician services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care services; and acute and chronic pain management services.

Featured Story: Bar Chart

Receive News & Ratings for MEDNAX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MEDNAX and related companies with MarketBeat.com's FREE daily email newsletter.